TY - JOUR AU - Curtis, R. E. PY - 1997 DA - 1997// TI - Solid Cancers after Bone Marrow Transplantation JO - N Engl J Med VL - 336 UR - https://doi.org/10.1056/NEJM199703273361301 DO - 10.1056/NEJM199703273361301 ID - Curtis1997 ER - TY - JOUR AU - Kaufman, H. PY - 2013 DA - 2013// TI - The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma JO - Nat Rev Clin Oncol VL - 10 UR - https://doi.org/10.1038/nrclinonc.2013.153 DO - 10.1038/nrclinonc.2013.153 ID - Kaufman2013 ER - TY - JOUR AU - Blazar, B. R. PY - 1999 DA - 1999// TI - Opposing Roles of CD28:B7 and CTLA-4:B7 Pathways in Regulating In Vivo Alloresponses in Murine Recipients of MHC Disparate T Cells JO - J Immunol VL - 162 ID - Blazar1999 ER - TY - JOUR AU - Blazar, B. R. PY - 2003 DA - 2003// TI - Blockade of Programmed Death-1 Engagement Accelerates Graft-Versus-Host Disease Lethality by an IFN- -Dependent Mechanism JO - J Immunol VL - 171 UR - https://doi.org/10.4049/jimmunol.171.3.1272 DO - 10.4049/jimmunol.171.3.1272 ID - Blazar2003 ER - TY - JOUR AU - Bashey, A. PY - 2009 DA - 2009// TI - CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation JO - Blood VL - 113 UR - https://doi.org/10.1182/blood-2008-07-168468 DO - 10.1182/blood-2008-07-168468 ID - Bashey2009 ER - TY - JOUR AU - Zhou, J. PY - 2011 DA - 2011// TI - CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells JO - Biol Blood Marrow Transplant VL - 17 UR - https://doi.org/10.1016/j.bbmt.2010.08.005 DO - 10.1016/j.bbmt.2010.08.005 ID - Zhou2011 ER - TY - JOUR AU - Saranga-Perry, V. PY - 2014 DA - 2014// TI - Recent developments in the medical and surgical treatment of melanoma JO - CA Cancer J Clin VL - 64 UR - https://doi.org/10.3322/caac.21224 DO - 10.3322/caac.21224 ID - Saranga-Perry2014 ER - TY - JOUR AU - Hodi, F. S. PY - 2010 DA - 2010// TI - Improved Survival with Ipilimumab in Patients with Metastatic Melanoma JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa1003466 DO - 10.1056/NEJMoa1003466 ID - Hodi2010 ER - TY - JOUR AU - Pavletic, S. Z. AU - Fowler, D. H. PY - 2012 DA - 2012// TI - Are we making progress in GVHD prophylaxis and treatment? JO - ASH Education Program Book VL - 2012 ID - Pavletic2012 ER - TY - STD TI - Flowers, M.E.D., Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria, ed. M.E.D. Flowers, et al. Vol. 117. 2011. 3214–3219. ID - ref10 ER -